Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

Comments

Popular posts from this blog

Apple to End Software Support for 16 iPad, Mac, Apple Watch and Apple TV Models With Latest Updates

NASA Spots Plankton Swarms from Space to Help Save North Atlantic Right Whales